Elevance Health inked a deal to acquire a specialty pharmacy that caters to patients with complex and chronic conditions like cancer and multiple sclerosis. The insurer said BioPlus will complement ...

Elevance has closed its deal to acquire specialty pharmacy BioPlus, the insurer announced Wednesday, after first announcing the buy in November 2022. The acquisition builds off the Indianapolis-based ...

Elevance Health has closed its acquisition of BioPlus, a specialty pharmacy company, the insurer announced Wednesday. BioPlus was a subsidiary of CarepathRx, part of Nautic Partners' portfolio.

New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. (“BIOS” or the “Company”) (Nasdaq: BIOS) announced today that (i) BIOS, Avertix Medical, Inc. and certain other parties have ...

Elevance Health has finalized its acquisition of BioPlus, a specialty pharmacy subsidiary of CarepathRx and a portfolio company of Nautic Partners, the insurer announced this week. BioPlus provides a ...

INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health (NYSE: ELV) today announced the closing of its acquisition of BioPlus, a comprehensive specialty pharmacy subsidiary of CarepathRx, a portfolio company ...

Elevance Health will acquire BioPlus in a bid to enhance its specialty pharmacy services, the company announced Wednesday morning. The insurer, formerly Anthem, has entered into an agreement with ...

Elevance Health, formerly Anthem, has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners, to acquire BioPlus, a comprehensive specialty pharmacy, the insurer announced ...